| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0078 | 0.9 |